Results
Orchid Pharma Q4 Revenue Flat at ₹238 Crore
Orchid Pharma reported Q4 FY26 standalone revenue of ₹238 Cr, flat YoY, with PAT up 7% to ₹30 Cr.
Full-year FY26 revenue declined 12% to ₹811 Cr, while PAT fell 58% to ₹45 Cr due to lower EBITDA margi
